help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 22, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1675
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/4/1263    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsigkou, A.
Right arrow Articles by Falorni, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsigkou, A.
Right arrow Articles by Falorni, A.
Related Collections
Right arrow Female Endocrinology
Right arrow Neuroendocrinology and Pituitary

Submitted on July 26, 2007
Accepted on January 14, 2008

High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency

Anastasia Tsigkou, Stefania Marzotti, Lavinia Borges, Annalisa Brozzetti, Fernando Reis, Paola Candeloro, Maria Luisa Bacosi, Vittorio Bini, Felice Petraglia, and Alberto Falorni*

From Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena (AT, LB, FR, FP), and Department of Internal Medicine, Section of Internal Medicine and Endocrine & Metabolic Sciences, University of Perugia, 06126 Perugia (SM, AB, PC, MLB, VB, AF), Italy

* To whom correspondence should be addressed. E-mail: falorni{at}dimisem.med.unipg.it.

Context: Primary Ovarian Insufficiency (POI) is defined by hypergonadotropic amenorrhea occurring before the age of 40 yrs. In 4–5% of women with POI, an ovarian autoimmune process can be demonstrated.

Design: We have determined the serum concentrations of total inhibin and inhibin B by sensitive ELISAs in 22 women with autoimmune POI (aPOI), 71 women with non-autoimmune, idiopathic POI (iPOI), 77 post-menopausal women (PMW) and 90 healthy, fertile women (HW). Diagnosis of aPOI was made according to the presence of steroid cell autoantibodies and/or 17{alpha}-hydroxylase autoantibodies and/or P450scc autoantibodies. All aPOI patients were also positive for adrenal autoantibodies.

Results: Total inhibin levels were significantly higher in women with aPOI (median: 281 pg/ml) than in women with iPOI (median: 74 pg/ml) or HW (median: 133.5 pg/ml) (p<0.001). Levels of inhibin B were also significantly higher in women with aPOI (median: 109 pg/ml) than in women with iPOI (median: 18 pg/ml) (p<0.001) or HW (median: 39 pg/ml) (p<0.05). Serum concentrations of total inhibin and inhibin B were significantly higher in women with POI than in PMW (p<0.001), irrespective of the presence/absence of autoantibodies. At ROC analysis, cut off-values of 133 pg/ml for total inhibin and 60.5 pg/ml for inhibin B ensured a 86.4% sensitivity and a 81–84.5% specificity for aPOI vs. iPOI.

Conclusions: We conclude that a variable degree of ovarian function is preserved in women with primary ovarian insufficiency and that aPOI is characterized by increased inhibin production resulting from a selective theca cell destruction, with initial preservation of granulosa cells.


Key words: autoantibodies • autoimmunity • inhibin • menopause • oophoritis • ovarian insufficiency







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society